Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts.
Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.
Crinetics Pharmaceuticals (CRNX) – This is a clinical-stage biotech company that develops novel treatments for rare endocrine diseases. Yesterday, H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on the stock with a price target of $81 per share. The analyst sees strong potential in Crinetics’ lead drug, Palsonify, following positive feedback from doctors. He also sees potential in the company’s Graves’ disease program, which may provide a safer treatment choice. In the last three months, all six Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 159.5%.
Backblaze (BLZE) – Backblaze is a cloud storage and backup provider that helps individuals and businesses securely store and recover data online. Yesterday, Craig-Hallum analyst Jeff Van Rhee maintained a Buy rating on the stock. In the last three months, all three Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 102.95%.
DraftKings (DKNG) – This is a digital sports entertainment and gaming company that offers online sports betting, fantasy sports, and casino games across multiple U.S. states. Yesterday, Bank of America Securities analyst Shaun Kelley maintained a Buy rating on the stock with a price target of $50 per share. Kelley is positive on DraftKings ahead of its Q2 results. He believes that the company’s cost-cutting initiatives will help drive margins and lead to an earnings beat in Q2. Interestingly, 24 out of the 25 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 22.37%.
Who Are the Top Analysts?
TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time.
See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page.